Endometrial cancer is the most common form of cancer of the female reproductive organs in the U.S., with 67,880 new cases diagnosed each year. Over the past decades, rates have increased and ...

Please provide your email address to receive an email when new articles are posted on . Use of vaginal estrogen therapy does not affect recurrence risk for women previously diagnosed with endometrial ...

Endometrial cancer strikes Black and white women at similar rates, but Black women are almost twice as likely to die of the disease, according to an analysis of government cancer data published in ...

Women who use vaginal estrogen to manage early menopause after treatment for endometrial cancer may not have an increased risk for recurrence.

Endometrial cancer, also known as uterine cancer, is the most common cancer of the female reproductive system. It begins in the lining of the uterus, called the endometrium. While it usually affects ...

Despite the increased incidence of endometrial cancer in younger women, there is limited research regarding the safety of local, low-dose vaginal estrogen therapy (ET) for survivors. A new study ...

—A new study from California-based researchers reports that things may be getting worse for certain women at risk for endometrial cancer. Here’s what the research team adds to what’s known about ...

The most common type of gynecologic cancer in the U.S. has been on the rise in recent years — and there’s no standard screening for it. Uterine cancer will affect about 66,200 women in 2023 in the U.S ...

A recent study has found that Black women may be at a higher risk for uterine cancer because of harmful chemicals in some hair straightening products. These chemicals affect your body’s hormones.

Acrivon Therapeutics (NASDAQ:ACRV) hosted a webcast featuring a key opinion leader (KOL) panel focused on the company’s ...

"I wasn’t reading the signs... I thought, ‘This is what it’s like to be in your 60s, and it’s just part and parcel of getting older,' " Kingston recalled ...